These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36701797)

  • 1. Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Buse DC; Nahas SJ; Stewart WBF; Armand CE; Reed ML; Fanning KM; Manack Adams A; Lipton RB
    J Occup Environ Med; 2023 Apr; 65(4):e261-e268. PubMed ID: 36701797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
    Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
    Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
    Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
    Buse DC; Sakai F; Matharu M; Reed ML; Fanning K; Dabruzzo B; Lipton RB
    Headache; 2024 May; 64(5):469-481. PubMed ID: 38706199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study.
    Hutchinson S; Lipton RB; Ailani J; Reed ML; Fanning KM; Adams AM; Buse DC
    Mayo Clin Proc; 2020 Apr; 95(4):709-718. PubMed ID: 32247344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of monthly headache days on migraine-related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.
    Lipton RB; Pozo-Rosich P; Orr SL; Reed ML; Fanning KM; Dabruzzo B; Buse DC
    Headache; 2023; 63(10):1448-1457. PubMed ID: 37795746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) cross-sectional study.
    Matharu M; Katsarava Z; Buse DC; Sommer K; Reed ML; Fanning KM; Lipton RB
    Headache; 2024; 64(7):750-763. PubMed ID: 38982663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study.
    Lipton RB; Lanteri-Minet M; Leroux E; Manack Adams A; Contreras-De Lama J; Reed ML; Fanning KM; Buse DC
    J Headache Pain; 2023 Nov; 24(1):151. PubMed ID: 37940856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
    Lipton RB; Munjal S; Buse DC; Alam A; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2019 Sep; 59(8):1310-1323. PubMed ID: 31410844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.
    Gibbs SN; Shah S; Deshpande CG; Bensink ME; Broder MS; Dumas PK; Buse DC; Vo P; Schwedt TJ
    Headache; 2020 Jul; 60(7):1351-1364. PubMed ID: 32369201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Work impact of migraine headaches.
    Stewart WF; Wood GC; Razzaghi H; Reed ML; Lipton RB
    J Occup Environ Med; 2008 Jul; 50(7):736-45. PubMed ID: 18617829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom.
    Vo P; Fang J; Bilitou A; Laflamme AK; Gupta S
    J Headache Pain; 2018 Sep; 19(1):82. PubMed ID: 30203163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study.
    Hirata K; Ueda K; Komori M; Zagar AJ; Selzler KJ; Nelson AM; Han Y; Jaffe DH; Matsumori Y; Takeshima T
    Curr Med Res Opin; 2021 Nov; 37(11):1945-1955. PubMed ID: 34429000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication Overuse and Headache Burden: Results From the CaMEO Study.
    Schwedt TJ; Buse DC; Argoff CE; Reed ML; Fanning KM; Hussar CR; Adams AM; Lipton RB
    Neurol Clin Pract; 2021 Jun; 11(3):216-226. PubMed ID: 34476122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB; Seng EK; Chu MK; Reed ML; Fanning KM; Adams AM; Buse DC
    Headache; 2020 Sep; 60(8):1683-1696. PubMed ID: 33448374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Serrano D; Manack AN; Reed ML; Buse DC; Varon SF; Lipton RB
    Value Health; 2013; 16(1):31-8. PubMed ID: 23337213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.
    Buse DC; Reed ML; Fanning KM; Bostic R; Dodick DW; Schwedt TJ; Munjal S; Singh P; Lipton RB
    J Headache Pain; 2020 Mar; 21(1):23. PubMed ID: 32122324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Employment and work impact of chronic migraine and episodic migraine.
    Stewart WF; Wood GC; Manack A; Varon SF; Buse DC; Lipton RB
    J Occup Environ Med; 2010 Jan; 52(1):8-14. PubMed ID: 20042889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Societal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey.
    García-Azorín D; Moya-Alarcón C; Armada B; Sánchez Del Río M
    J Headache Pain; 2024 Mar; 25(1):38. PubMed ID: 38486155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.